Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,043 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00012207

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington School of Medicine Seattle, Washington, United States

View Trial Details

Completed

German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

NCT00199017

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University Hospital, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

NCT00199004

Conditions: Adult Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia

NCT00286780

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UCSD Moores Cancer Center San Diego, California, United States

View Trial Details

Completed

Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

NCT00188929

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

NCT00232440

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +8 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

NCT01177371

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

UCN-01 in Treating Patients With Advanced Cancer

NCT00003289

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

NCT00083460

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

Multicenter Cross Sectional Study of Primary Intestine Lymphoma

NCT01043302

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions